Sort
50,496 grants matching “lung cancer”
Identification of viral exposure signatures for early detection of liver cancer
$518,132Limin Wang · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach
$517,978David O. Francis · University Of Wisconsin-Madison · R01 · FY2021 · CA
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
$517,965Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · CA
A dual-layer flat panel x-ray detector based on an engineered amorphous chalcogenide alloy for quantifying coronary artery calcium
$517,942Shiva Abbaszadeh · University Of California Santa Cruz · R01 · FY2022 · EB
Tumor and Metastasis Biology
$517,906Lee J. Helman · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
$517,885Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
$517,839Kristine L Kwekkeboom · University Of Wisconsin-Madison · R01 · FY2014 · NR
Nonmyeloablative allogeneic PBSC in globin disorders
$517,763John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Improving Radiologist Detection of Lung Nodules with CAD
$517,741Sandy A Napel · Stanford University · R01 · FY2008 · CA
Clinical Core
$517,656Philip C Mack · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA
Community Engagement Core: Community Engagement will include Dialogue, Advocacy, and Research (CEDAR)
$517,642Myra Elizabeth Parker · Fred Hutchinson Cancer Center · U19 · FY2025 · MD
CLINICAL CORE
$517,634Joel L Weissfield · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$517,622Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The Role of Protein Kinases in NRF2-driven Lung Squamous Cell Carcinoma
$517,517Michael Benjamin Major · Washington University · R01 · FY2020 · CA
Addressing Fugitive Chemical Health Risks through Community-Based Actions
$517,508Ramya Chari · Rand Corporation · R01 · FY2016 · ES
Vaccine and radiation for the therapy of human cancers
$517,502James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$517,502James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection
$517,485Steven A Belinsky · Johns Hopkins University · P50 · FY2010 · CA
Integrated 3D Xray and Dynamic Tomographic Optical Breast Imaging System
$517,420David A Boas · Massachusetts General Hospital · R01 · FY2013 · CA
Molecular Dynamics Simulations Of Biological Macromolecules
$517,416Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
$517,386Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
Computational Tools for Next Generation Volumetric Cone Beam Computed Tomography
$517,384Lei Xing · Stanford University · R01 · FY2016 · EB
Clinical trials employing cancer vaccine combination therapies
$517,380James L. Gulley · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$517,380James L. Gulley · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$517,329Anton Wellstein · Georgetown University · R01 · FY2019 · CA